News
Twenty European countries issue patent on EquiSeq DNA tests
ALBUQUERQUE, NEW MEXICO EquiSeq announced today that a group of twenty countries in Europe have issued a patent on EquiSeq’s DNA test for three genetic variants that predispose to muscle disease. The tests are part of EquiSeq’s current DNA panel. Test results allow horse owners to better manage affected horses, and can be used to…
Read MoreJeremy Edwards speaks on intellectual property
Jeremy Edwards, Chair of Department of Chemistry and Chemical Biology at the University of New Mexico, is one of UNM’s most prolific inventors. Dr. Edwards is part of the EquiSeq science team and is an inventor on two of EquiSeq’s patents. In this interview, Dr. Edwards talks about the importance of protecting intellectual property.
Read MoreSouth Africa issues patent on EquiSeq DNA tests
ALBUQUERQUE, NEW MEXICO EquiSeq announced today that South Africa has issued a patent on EquiSeq’s DNA tests for three genetic variants in horses that predispose to muscle disease. The tests are part of EquiSeq’s current DNA panel. Test results allow horse owners to better manage affected horses, and can be used to improve a breeding…
Read MoreNew Zealand issues patent on EquiSeq DNA tests
ALBUQUERQUE, NEW MEXICO EquiSeq announced today that New Zealand has issued a patent on EquiSeq’s DNA tests for three genetic variants in horses that predispose to muscle disease. The tests are part of EquiSeq’s current DNA panel. Test results allow horse owners to better manage affected horses, and can be used to improve a breeding…
Read MoreCanada issues patent on EquiSeq DNA tests
ALBUQUERQUE, NEW MEXICO EquiSeq announced today that Canada has issued a patent on EquiSeq’s DNA tests for three genetic variants in horses that predispose to muscle disease. The tests are part of EquiSeq’s current DNA panel. Test results allow horse owners to better manage affected horses, and can be used to improve a breeding program…
Read MoreGeneratio Scientist Visits EquiSeq
Dr. Melissa Cox, a scientist at Generatio, visited with Chief Scientific Officer Dr. Paul Szauter at EquiSeq’s office in Albuquerque. Dr. Cox was visiting for a friend’s wedding, and made time for a two-hour discussion of scientific work at Generatio GmbH. Dr. Cox reviewed the results of a survey of horse owners exploring symptoms in…
Read MoreFree Testing for Standardbreds and Haflingers
Albuquerque, New Mexico A collaborative research team assembled by researchers at EquiSeq will end its offer of free testing for Standardbreds and Haflingers on March 31, 2023. The project is aimed at studying the K1 variant of COL6A3, which is present in high frequency in these breeds. The K1 variant affects the structure of collagen…
Read MorePaul Szauter Invited to Speak at Genome Sciences Symposium
Seattle, WA Paul Szauter, EquiSeq’s Chief Scientific Officer, has been invited to speak at the Genome Sciences 20th Anniversary Symposium at the University of Washington in Seattle. The Symposium will be held November 10 – 11; the schedule includes presentations by Bill Gates, Francis Collins, George Church, and Genome Sciences Chair Robert Waterston. Dr. Szauter received his…
Read MoreFree Testing Expands Standardbred Genetics Research
Albuquerque, New Mexico EquiSeq has expanded its research program on the genetics of Standardbreds by offering free testing to owners of purebred horses. Standardbred owners in the United States can receive EquiSeq’s Myopathy Panel at no cost. Standardbred owners received consent forms and sample kits beginning in December 2021, expanding an earlier survey of the…
Read MoreConnemara Pony PSSM Research Group Partners with Generatio GmbH
Bergen, Norway The Connemara Pony PSSM Research Group is now registered as a DNA Program with Generatio GmbH – Center for Animal Genetics (CAG). The research group is a small international group of knowledgeable Connemara-people independent of any breed society. We are gathering data with the aim to map the prevalence of the genetic variants…
Read More